½ÃÀ庸°í¼­
»óǰÄÚµå
1612566

¼¼°èÀÇ »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀå : À¯Çü, Á¦Ç° À¯Çü, ÃÖÁ¾ ¿ëµµ, ¿ëµµº° ¿¹Ãø(2025-2030³â)

Biological Sample Handling Market by Type (Cellular & Genetic Material, Saliva Samples, Stool Samples), Product (Blood Collection Kits, Swabs, Viral Transport Media), End-Use, Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 196 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

»ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀåÀº 2023³â¿¡ 186¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 198¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 6.47%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 288¾ï 8,000¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

»ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀåÀº »ý¹°ÇÐÀû »ùÇÃÀÇ È¿°úÀûÀÎ °ü¸®, ó¸® ¹× º¸Á¸¿¡ ÇÊ¿äÇÑ ±¤¹üÀ§ÇÑ È°µ¿À» Æ÷ÇÔÇÕ´Ï´Ù. ¹«°á¼º°ú »ýÁ¸¼ºÀ» À¯ÁöÇϱâ À§ÇØ ÇʼöÀûÀÔ´Ï´Ù. ÀÓ»ó½ÃÇè, ¿ªÇÐ ¿¬±¸ ¹× ¸ÂÃãÇü ÀÇ·á¿¡¼­ Á¤È®ÇÏ°í ½Å·ÚÇÒ ¼öÀÖ´Â °á°ú¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó °ß°íÇÑ »ùÇà ó¸®ÀÇ Çʿ伺ÀÌ ¹ß»ýÇß½À´Ï´Ù. º´¿ø, ¿¬±¸±â°ü, Á¦¾àȸ»ç¿¡ À̸£°í ÀÖ½À´Ï´Ù. ¼ºÀå¿¡ ¿µÇâÀ» ÁÖ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ¸¸¼ºÁúȯ Áõ°¡, »ý¸í°øÇÐÀÇ Áøº¸, °íǰÁúÀÇ »ùÇà °ü¸®¸¦ ÇÊ¿ä·Î ÇÏ´Â À¯Àüü ¿¬±¸ÀÇ È®´ë µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¤¹ÐÀÇ·á ¹× ¸ÂÃãÇü ÀÇ·á¿¡ÀÇ °ü½ÉÀÇ ³ô¾ÆÁüµµ ÁÖ¸ñµÇ¾î Ãë±Þ ¼ø¼­ÀÇ °­È­°¡ ÇÊ¿äÇØÁö°í ÀÖ½À´Ï´Ù. ¼ö ÀÖ½À´Ï´Ù ±â¾÷Àº µ¥ÀÌÅ͸¦ ¿Ï·áÇÕ´Ï´Ù. ¹«°á¼ºÀ» À§ÇÑ ºí·ÏüÀΰú ¿¹ÃøÀû »ùÇà ºÐ¼®À» À§ÇÑ AI µîÀÇ ºÐ¾ß¸¦ Ȱ¿ëÇÏ¿© °æÀï·ÂÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. °ü·Ã °íºñ¿ë, ½ÅÈï±¹ Áö¿ª¿¡¼­ Á¦ÇÑµÈ ÀÎ½Ä µîÀÌ ÀÖ½À´Ï´Ù. ǰÁú °ü¸® ¹®Á¦µµ ½ÃÀå °³Ã´¿¡ Å« À§ÇèÀ» °¡Á®¿É´Ï´Ù. ´õ ³ªÀº µ¥ÀÌÅÍ °ü¸®¿¡ ´ëÇÑ ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½ºÀÇ °­È­°¡ Æ÷ÇԵ˴ϴÙ. »õ·Î¿î º¸Á¸ ¹æ¹ýÀÇ ¿¬±¸³ª, ȯ°æ ģȭÀûÀÌ°í ºñ¿ë È¿À²ÀûÀÎ º¸Á¸ ¼Ö·ç¼ÇÀÇ °³¹ßµµ, ¼ºÀåÀ» °¡¼ÓÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ±×¸®°í, ±â¼úÀû Áøº¸¿Í ÁÖ¿ä ±â¾÷ °£ÀÇ ÆÄÆ®³Ê½Ê¿¡ ÃÊÁ¡À» ¸ÂÃß¾î ¾÷¹«ÀÇ ÇÕ¸®È­¿Í »ç¾÷ ¹üÀ§ÀÇ È®´ë¸¦ µµ¸ðÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 186¾ï 2,000¸¸ ´Þ·¯
ÃßÁ¤³â(2024) 198¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 288¾ï 8,000¸¸ ´Þ·¯
CAGR(%) 6.47%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

»ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. Á¤¹ÐÈ­ ¹× »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñ ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ÀÌ´Â Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ¿í ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °³º°È­ ÇコÄɾ À־ÀÇ À¯Ã¼ »ùÇà °ü¸®¿Í Çڵ鸵¿¡ÀÇ ¿ä±¸ÀÇ °íÁ¶
    • À¯ÀüüÇÐ¿Í ´Ü¹éÁúüÇп¡ ÀÇÇÑ ¼ö¿ä Áõ°¡¿Í ¹ÙÀÌ¿À¹ðÅ· Áõ°¡
    • ¹ÙÀÌ¿À¸¶Ä¿ ºÐ¼®ÀÇ ±Þ¼ºÀå°ú °í±Þ »ùÇà Ãë±ÞÀÇ Çʿ伺
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • »ý¹°ÇÐÀû »ùÇà Ãë±Þ¿Í °ü·ÃµÈ ¾ö°ÝÇÑ ±ÔÁ¦
  • ½ÃÀå ±âȸ
    • »ý¸í °úÇÐ ¿¬±¸ °³¹ß Ȱµ¿¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
    • »ùÇà Çڵ鸵¿¡ À־ÀÇ ±â¼úÀÇ Áøº¸¿Í Çõ½Å
  • ½ÃÀåÀÇ °úÁ¦
    • Á¶ÀÛ¿¡ µû¸¥ º¹À⼺°ú ƯÁ¤ Çڵ鸵 ÇÁ·ÎÅäÄÝÀÇ Çʿ伺

Porter's Five Force : »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ȸÇÇÇÔÀ¸·Î½á º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ÕÀ» ³»´Ùº¸°í Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

»ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

»ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • °³ÀÎÈ­µÈ °Ç°­ °ü¸®¿¡¼­ ü¾× »ùÇà °ü¸® ¹× Ãë±Þ Çʿ伺 Áõ°¡
      • À¯ÀüüÇÐ¿Í ´Ü¹éÁúüÇзκÎÅÍ ¼ö¿ä Áõ°¡¿Í ¹ÙÀÌ¿À¹ðÅ·ÀÇ ½Çõ Áõ°¡
      • ¹ÙÀÌ¿À¸¶Ä¿ ºÐ¼®ÀÇ ±Þ°ÝÇÑ Áõ°¡¿Í °í±Þ »ùÇà Ãë±ÞÀÇ Çʿ伺
    • ¾ïÁ¦¿äÀÎ
      • »ý¹°ÇÐÀû »ùÇà Ãë±Þ°ú °ü·ÃµÈ ¾ö°ÝÇÑ ±ÔÁ¤
    • ±âȸ
      • »ý¸í °úÇÐ ¿¬±¸ °³¹ß Ȱµ¿¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
      • »ùÇà Ãë±Þ¿¡ À־ÀÇ ±â¼úÀû Áøº¸¿Í Çõ½Å
    • °úÁ¦
      • Á¶ÀÛ¿¡ µû¸¥ º¹À⼺°ú ƯÁ¤ ó¸® ÇÁ·ÎÅäÄÝÀÇ Çʿ伺
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • Á¦Ç° : ¼ö¼Û Áß¿¡ ¹ÙÀÌ·¯½º »ùÇÃÀ» º¸Á¸Çϱâ À§ÇÑ Ã¤Ç÷ ŰƮ¿Í ¸éºÀÀÇ »ç¿ëÀÌ Áõ°¡
    • ÃÖÁ¾ ¿ëµµ: Àû±ØÀûÀÎ °Ç°­ °ü¸®¸¦ ÃßÁøÇÏ´Â º´¿ø¿¡¼­ÀÇ »ý¹°ÇÐÀû »ùÇà Ãë±Þ ¼Ö·ç¼ÇÀÇ Ã¤¿ë Áõ°¡
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀå : À¯Çüº°

  • ¼¼Æ÷¿Í À¯Àü¹°Áú
  • Ÿ¾× »ùÇÃ
  • ´ëº¯ »ùÇÃ
  • ¼Òº¯ »ùÇÃ

Á¦7Àå »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀå : Á¦Ç°º°

  • äÇ÷ ŰƮ
  • ¸éºÀ
    • ºñ°­ ½º¿Íºê
    • ºñÀεΠ½º¿Íºê
    • ±¸°­ ÀεΠ¸éºÀ
  • ¹ÙÀÌ·¯½º Àü´Þ ¹èÁö

Á¦8Àå »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • Áø´Ü¼¾ÅÍ
  • ȨÄɾî
  • º´¿ø ¹× Ŭ¸®´Ð

Á¦9Àå »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀå : ¿ëµµº°

  • Áø´Ü
  • Á¶»ç

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ »ý¹°ÇÐÀû »ùÇà Ãë±Þ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • MedLife, µå·ÐÀ¸·Î ½ÇÇè½Ç »ùÇÃÀ» ¼ö¼Û
    • BioLizard¿Í Parean Biotechnologies°¡ Á¦ÈÞ¸¦ ¹ßÇ¥
    • MolGenÀÌ Synchron Lab Automation Àμö
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Accelerated Laboratory Logistics
  • Alliance Pharma PLC
  • Azenta Life Sciences
  • BioDock Limited
  • BioLife Solutions Inc.
  • Clinigen Group
  • Cryoniss
  • Cryoport Systems, LLC
  • Discovery Life Sciences
  • Eppendorf SE
  • Hamilton Company
  • Infiuss Health
  • Labtoo
  • Marken by United Parcel Service, Inc.
  • Mercury Business Services
  • MLM Medical Labs
  • Oximio
  • PrecisionMed, LLC
  • ReproCELL Inc.
  • SAROUTE Co., Ltd.
  • SPT Labtech Ltd.
  • Thermo Fisher Scientific Inc.
  • Ziath Ltd.
JHS 24.12.24

The Biological Sample Handling Market was valued at USD 18.62 billion in 2023, expected to reach USD 19.85 billion in 2024, and is projected to grow at a CAGR of 6.47%, to USD 28.88 billion by 2030.

The biological sample handling market encompasses a wide range of activities necessary for the effective management, processing, and preservation of biological samples. This process is vital for maintaining the integrity and viability of samples used in diagnostic testing, drug discovery, and biobanking. The necessity of robust sample handling practices arises from the increased demand for precise and reliable results in clinical trials, epidemiological studies, and personalized medicine. Applications of sample handling are broad, spanning clinical laboratories, hospitals, research institutions, and pharmaceutical companies. Key influencing growth factors include the rise in chronic diseases, advancements in biotechnologies, and the expansion of genomic research requiring high-quality sample management. Also noteworthy is the burgeoning interest in precision medicine and personalized healthcare, necessitating enhanced handling procedures. Emerging opportunities exist in automation and innovative technologies like cryopreservation and automated storage systems, which can greatly enhance sample management efficiency. Companies can capitalize on areas such as blockchain for data integrity and AI for predictive sample analytics to gain a competitive edge. However, challenges to market growth include stringent regulatory requirements, high costs associated with advanced handling technologies, and limited awareness in developing regions. Quality control issues also pose a substantial risk to market development. The best areas for innovation involve improving sustainability practices, integrating IoT for real-time monitoring, and enhancing bioinformatics for better data management. Research into novel preservation methods and the development of eco-friendly, cost-effective storage solutions can also foster growth. The market is highly dynamic in nature, with a focus on technological advancements and partnerships among key players to streamline operations and expand reach. Businesses should prioritize continuous innovation and strategic collaborations to mitigate challenges and leverage emerging opportunities effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 18.62 billion
Estimated Year [2024] USD 19.85 billion
Forecast Year [2030] USD 28.88 billion
CAGR (%) 6.47%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biological Sample Handling Market

The Biological Sample Handling Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for fluid sample management and handling in personalized healthcare
    • Growing demand from genomics and proteomics and the rise in biobanking practices
    • Exponential growth of biomarker analysis and the need for sophisticated sample handling
  • Market Restraints
    • Strict regulations associated with biological sample handling
  • Market Opportunities
    • Increasing investment in life sciences R&D activities
    • Technological advancements and innovations in sample handling
  • Market Challenges
    • Complexity associated with operations and need for specific handling protocols

Porter's Five Forces: A Strategic Tool for Navigating the Biological Sample Handling Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biological Sample Handling Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biological Sample Handling Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biological Sample Handling Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biological Sample Handling Market

A detailed market share analysis in the Biological Sample Handling Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biological Sample Handling Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biological Sample Handling Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biological Sample Handling Market

A strategic analysis of the Biological Sample Handling Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biological Sample Handling Market, highlighting leading vendors and their innovative profiles. These include Accelerated Laboratory Logistics, Alliance Pharma PLC, Azenta Life Sciences, BioDock Limited, BioLife Solutions Inc., Clinigen Group, Cryoniss, Cryoport Systems, LLC, Discovery Life Sciences, Eppendorf SE, Hamilton Company, Infiuss Health, Labtoo, Marken by United Parcel Service, Inc., Mercury Business Services, MLM Medical Labs, Oximio, PrecisionMed, LLC, ReproCELL Inc., SAROUTE Co., Ltd., SPT Labtech Ltd., Thermo Fisher Scientific Inc., and Ziath Ltd..

Market Segmentation & Coverage

This research report categorizes the Biological Sample Handling Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Cellular & Genetic Material, Saliva Samples, Stool Samples, and Urine Samples.
  • Based on Product, market is studied across Blood Collection Kits, Swabs, and Viral Transport Media. The Swabs is further studied across Nasal Swabs, Nasopharyngeal Swabs, and Oropharyngeal Swabs.
  • Based on End-Use, market is studied across Diagnostic Centers, Homecare, and Hospitals & Clinics.
  • Based on Application, market is studied across Diagnostics and Research.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for fluid sample management and handling in personalized healthcare
      • 5.1.1.2. Growing demand from genomics and proteomics and the rise in biobanking practices
      • 5.1.1.3. Exponential growth of biomarker analysis and the need for sophisticated sample handling
    • 5.1.2. Restraints
      • 5.1.2.1. Strict regulations associated with biological sample handling
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment in life sciences R&D activities
      • 5.1.3.2. Technological advancements and innovations in sample handling
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity associated with operations and need for specific handling protocols
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing usage of blood collection kits and swabs for preserving viral samples during transportation
    • 5.2.2. End-Use: Increasing adoption of biological sample handling solutions in hospitals promoting proactive health management
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biological Sample Handling Market, by Type

  • 6.1. Introduction
  • 6.2. Cellular & Genetic Material
  • 6.3. Saliva Samples
  • 6.4. Stool Samples
  • 6.5. Urine Samples

7. Biological Sample Handling Market, by Product

  • 7.1. Introduction
  • 7.2. Blood Collection Kits
  • 7.3. Swabs
    • 7.3.1. Nasal Swabs
    • 7.3.2. Nasopharyngeal Swabs
    • 7.3.3. Oropharyngeal Swabs
  • 7.4. Viral Transport Media

8. Biological Sample Handling Market, by End-Use

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Homecare
  • 8.4. Hospitals & Clinics

9. Biological Sample Handling Market, by Application

  • 9.1. Introduction
  • 9.2. Diagnostics
  • 9.3. Research

10. Americas Biological Sample Handling Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biological Sample Handling Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biological Sample Handling Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. MedLife to Transport Lab Samples with Drones
    • 13.3.2. BioLizard and Parean Biotechnologies Announce Partnership
    • 13.3.3. MolGen Acquires Synchron Lab Automation
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accelerated Laboratory Logistics
  • 2. Alliance Pharma PLC
  • 3. Azenta Life Sciences
  • 4. BioDock Limited
  • 5. BioLife Solutions Inc.
  • 6. Clinigen Group
  • 7. Cryoniss
  • 8. Cryoport Systems, LLC
  • 9. Discovery Life Sciences
  • 10. Eppendorf SE
  • 11. Hamilton Company
  • 12. Infiuss Health
  • 13. Labtoo
  • 14. Marken by United Parcel Service, Inc.
  • 15. Mercury Business Services
  • 16. MLM Medical Labs
  • 17. Oximio
  • 18. PrecisionMed, LLC
  • 19. ReproCELL Inc.
  • 20. SAROUTE Co., Ltd.
  • 21. SPT Labtech Ltd.
  • 22. Thermo Fisher Scientific Inc.
  • 23. Ziath Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦